These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8329786)

  • 21. Stability of famotidine in polyvinyl chloride minibags and polypropylene syringes and compatibility of famotidine with selected drugs.
    Keyi X; Gagnon N; Bisson C; Desmarais M; LeBel M
    Ann Pharmacother; 1993 Apr; 27(4):422-6. PubMed ID: 8477115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visual compatibility of oritavancin diphosphate with selected coadministered drugs during simulated Y-site administration.
    Kumar A; Mann HJ
    Am J Health Syst Pharm; 2010 Oct; 67(19):1640-4. PubMed ID: 20852166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physical compatibility and chemical stability of amphotericin B in combination with magnesium sulfate in 5% dextrose injection.
    Raymond GG; Davis RL
    DICP; 1991 Feb; 25(2):123-6. PubMed ID: 2058182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration.
    Avery LM; Chen IH; Reyes S; Nicolau DP; Kuti JL
    Clin Ther; 2019 Oct; 41(10):2162-2170. PubMed ID: 31506218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physical compatibility of tedizolid phosphate with selected i.v. drugs during simulated Y-site administration.
    Ghazi I; Hamada Y; Nicolau DP
    Am J Health Syst Pharm; 2016 Nov; 73(21):1769-1776. PubMed ID: 27769972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compatibility of filgrastim with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Aug; 51(15):1907-13. PubMed ID: 7524319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utilization of the tyndall effect for enhanced visual detection of particles in compatibility testing of intravenous fluids: validity and reliability.
    Staven V; Waaseth M; Wang S; Grønlie I; Tho I
    PDA J Pharm Sci Technol; 2015; 69(2):270-83. PubMed ID: 25868993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compatibility of propranolol hydrochloride injection with intravenous infusion fluids in plastic containers.
    Cummings DS; Park MK; Howard AB
    Am J Hosp Pharm; 1982 Oct; 39(10):1685-7. PubMed ID: 7148843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Feb; 51(4):495-9. PubMed ID: 8017415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compatibility and stability of linezolid injection admixed with three cephalosporin antibiotics.
    Xu QA; Trissel LA; Williams KY
    J Am Pharm Assoc (Wash); 2000; 40(4):509-14. PubMed ID: 10932460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of flumazenil with selected drugs in 5% dextrose injection.
    Olsen KM; Gurley BJ; Davis GA; Christensen R; Monaghan MS
    Am J Hosp Pharm; 1993 Sep; 50(9):1907-12. PubMed ID: 8135238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of visual and turbidimetric methods for determining short-term compatibility of intravenous critical-care drugs.
    Dasta JF; Hale KN; Stauffer GL; Tschampel MM
    Am J Hosp Pharm; 1988 Nov; 45(11):2361-6. PubMed ID: 3228093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visual compatibility of gallium nitrate with selected drugs during simulated Y-site injection.
    Lober CA; Dollard PA
    Am J Hosp Pharm; 1993 Jun; 50(6):1208-10. PubMed ID: 8517464
    [No Abstract]   [Full Text] [Related]  

  • 34. Turbidimetric assessment of the compatibility of taxol with selected other drugs during simulated Y-site injection.
    Trissel LA; Bready BB
    Am J Hosp Pharm; 1992 Jul; 49(7):1716-9. PubMed ID: 1352424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stability and compatibility of vancomycin for administration by continuous infusion.
    Raverdy V; Ampe E; Hecq JD; Tulkens PM
    J Antimicrob Chemother; 2013 May; 68(5):1179-82. PubMed ID: 23302579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compatibility of cisplatin and fluorouracil in 0.9% sodium chloride injection.
    Stewart CF; Fleming RA
    Am J Hosp Pharm; 1990 Jun; 47(6):1373-7. PubMed ID: 2368735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physico-chemical stability of butorphanol-tramadol and butorphanol-fentanyl patient-controlled analgesia infusion solutions over 168 hours.
    Chen F; Fang B; Li P; Zhu X; Zhou B
    Pharmazie; 2014 Aug; 69(8):585-8. PubMed ID: 25158568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compatibility of ceftazidime and aminophylline admixtures for different methods of intravenous infusion.
    Pleasants RA; Vaughan LM; Williams DM; Fox JL
    Ann Pharmacother; 1992 Oct; 26(10):1221-6. PubMed ID: 1421642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compatibility of Omadacycline With Select Parenteral Products in Simulated Y-site Administration.
    Butler DA; Moolick K; McCray D; Gifford M
    Clin Ther; 2023 Nov; 45(11):1137-1141. PubMed ID: 37777376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physical compatibility of colistin with analgesics during simulated Y-site administration.
    Dettlaff K; Kowalska A; Gostyńska A
    Am J Health Syst Pharm; 2024 Jun; 81(13):e365-e371. PubMed ID: 38358317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.